John Alexander's most recent trade in Uber Technologies Inc was a trade of 350 shares done . Disclosure was reported to the exchange on Oct. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2026 | 350 | 187,575 (0%) | 0% | - | - | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 12 Oct 2026 | 400 | 10,749 (0%) | 0% | 16.4 | 6,560 | - | |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 67.28 per share. | 18 Sep 2026 | 1,896 | 107,806 (0%) | 0% | 67.3 | 127,563 | Ordinary Shares |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 64.83 per share. | 17 Sep 2026 | 3,126 | 109,702 (0%) | 0% | 64.8 | 202,659 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Sep 2026 | 414 | 10,349 (0%) | 0% | 15.9 | 6,562 | - | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Aug 2026 | 362 | 9,614 (0%) | 0% | 18.1 | 6,550 | Ords | |
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 349 | 187,225 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 16 Jul 2026 | 349 | 0 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Jul 2026 | 436 | 9,252 (0%) | 0% | 15.0 | 6,553 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Jul 2026 | 349 | 349 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 67.87 per share. | 17 Jun 2026 | 3,186 | 114,437 (0%) | 0% | 67.9 | 216,234 | Ordinary Shares |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 66.98 per share. | 17 Jun 2026 | 1,847 | 112,590 (0%) | 0% | 67.0 | 123,712 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Jun 2026 | 441 | 8,736 (0%) | 0% | 14.9 | 6,562 | Ords 0.29p | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 08 Jun 2026 | 49 | 8,785 (0%) | 0% | 15.3 | 749 | Ords 0.29p | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 08 Jun 2026 | 31 | 8,816 (0%) | 0% | 15.3 | 474 | Ords 0.29p | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 01 Jun 2026 | 193,688 | 193,688 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.80 per share. | 26 May 2026 | 400 | 118,023 (0%) | 0% | 55.8 | 22,320 | Ordinary Shares |
| Ambarella Inc | Mr. John Alexander Young | CFO | 26 May 2026 | 400 | 24,600 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 26 May 2026 | 400 | 117,623 (0%) | 0% | 96 | 38,400 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 11 May 2026 | 425 | 8,295 (0%) | 0% | 15.4 | 6,566 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 03 May 2026 | 4,091 | 0 | - | - | Restricted Stock Units | ||
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2026 | 4,091 | 186,876 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 03 May 2026 | 4,045 | 4,045 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 21 Apr 2026 | 1,971 | 117,623 (0%) | 0% | 60 | 118,260 | Ordinary Shares |
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 338 | 182,785 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 16 Apr 2026 | 338 | 0 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Apr 2026 | 446 | 7,870 (0%) | 0% | 14.7 | 6,561 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Apr 2026 | 338 | 338 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2026 | 5,560 | 122,632 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 52.77 per share. | 17 Mar 2026 | 4,577 | 117,072 (0%) | 0% | 52.8 | 241,528 | Ordinary Shares |
| Ambarella Inc | Mr. John Alexander Young | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2026 | 3,556 | 121,649 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Mr. John Alexander Young | CFO | 17 Mar 2026 | 3,556 | 0 | - | - | Performance Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 54.14 per share. | 17 Mar 2026 | 3,038 | 119,594 (0%) | 0% | 54.1 | 164,477 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Mar 2026 | 432 | 7,424 (0%) | 0% | 15.2 | 6,558 | Ords 0.29p | |
| Ambarella Inc | Mr. John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 15,201 | 117,939 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | Mr. John Alexander Young | CFO | 02 Mar 2026 | 15,201 | 15,201 | - | - | Performance Stock Units | ||
| KBR Inc | Sir John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,212 | 17,546 (0%) | 0% | 0 | Common Stock | |
| KBR Inc | Sir John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,212 | 17,546 (0%) | 0% | 0 | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2026 | 27,584 | 134,032 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 17 Feb 2026 | 27,584 | 55,166 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2026 | 27,584 | 134,032 (0%) | 0% | 0 | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2026 | 27,584 | 134,032 (0%) | 0% | 0 | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 17 Feb 2026 | 8,149 | 125,883 (0%) | 0% | 3.8 | 31,292 | Common Stock |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 17 Feb 2026 | 8,149 | 125,883 (0%) | 0% | 3.8 | 31,292 | - |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 17 Feb 2026 | 8,149 | 125,883 (0%) | 0% | 3.8 | 31,292 | - |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Feb 2026 | 365 | 6,992 (0%) | 0% | 18.0 | 6,566 | Ords 0.29p | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 20 Jan 2026 | 26,575 | 26,575 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 26,575 | 121,661 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 26,575 | 121,661 (0%) | 0% | - | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 26,575 | 121,661 (0%) | 0% | - | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 15,213 | 106,448 (0%) | 0% | 4.0 | 61,308 | Common Stock |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 15,213 | 106,448 (0%) | 0% | 4.0 | 61,308 | - |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 15,213 | 106,448 (0%) | 0% | 4.0 | 61,308 | - |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 20 Jan 2026 | 13,900 | 13,901 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,900 | 95,086 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,900 | 95,086 (0%) | 0% | - | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,900 | 95,086 (0%) | 0% | - | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 20 Jan 2026 | 3,888 | 0 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 3,888 | 81,186 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 3,888 | 81,186 (0%) | 0% | - | - | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 3,888 | 81,186 (0%) | 0% | - | - | |
| Uber | Mr. John Alexander Thain | Director | 16 Jan 2026 | 297 | 0 | - | - | Restricted Stock Units | ||
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2026 | 297 | 182,447 (0%) | 0% | - | Common Stock | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 12 Jan 2026 | 397 | 6,543 (0%) | 0% | 16.5 | 6,547 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Jan 2026 | 297 | 297 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 72.96 per share. | 17 Dec 2025 | 3,791 | 102,738 (0%) | 0% | 73.0 | 276,591 | Ordinary Shares |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 71.82 per share. | 17 Dec 2025 | 2,579 | 106,529 (0%) | 0% | 71.8 | 185,224 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Dec 2025 | 410 | 6,146 (0%) | 0% | 16 | 6,560 | Ords 0.29p | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 04 Dec 2025 | 84 | 6,627 (0%) | 0% | 17.7 | 1,487 | Ords 0.29p | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Nov 2025 | 355 | 5,736 (0%) | 0% | 18.5 | 6,568 | Ords 0.29p | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2025 | 3,605 | 78,601 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 02 Nov 2025 | 3,605 | 0 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.49 per share. | 02 Nov 2025 | 1,303 | 77,298 (0%) | 0% | 6.5 | 8,456 | Common Stock |
| Uber | Mr. John Alexander Thain | Director | 16 Oct 2025 | 261 | 0 | - | - | Restricted Stock Units | ||
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 261 | 182,150 (0%) | 0% | - | Common Stock | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Oct 2025 | 358 | 5,381 (0%) | 0% | 18.3 | 6,562 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Oct 2025 | 261 | 261 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 09 Oct 2025 | 340 | 5,023 (0%) | 0% | 19.3 | 6,552 | Ords 0.29p | |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 79.43 per share. | 17 Sep 2025 | 2,566 | 109,108 (0%) | 0% | 79.4 | 203,817 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 11 Aug 2025 | 321 | 5,004 (0%) | 0% | 20.5 | 6,568 | Ords 28.94p | |
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 278 | 181,889 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 16 Jul 2025 | 278 | 0 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Jul 2025 | 335 | 4,683 (0%) | 0% | 19.5 | 6,549 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Jul 2025 | 278 | 278 | - | - | Restricted Stock Units | ||
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.26 per share. | 03 Jul 2025 | 14,827 | 73,485 (0%) | 0% | 4.3 | 63,163 | Common Stock |
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 52.26 per share. | 17 Jun 2025 | 2,435 | 111,451 (0%) | 0% | 52.3 | 127,253 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Jun 2025 | 331 | 4,348 (0%) | 0% | 19.8 | 6,570 | Ords 0.29p | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 02 Jun 2025 | 82,750 | 82,750 | - | - | Restricted Stock Units | ||
| KBR Inc | Sir John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 91 | 13,334 (0%) | 0% | 0 | Common Stock | |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 12 May 2025 | 299 | 3,973 (0%) | 0% | 21.9 | 6,560 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 04 May 2025 | 4,091 | 4,091 | - | - | Restricted Stock Units | ||
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2025 | 3,782 | 181,611 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 04 May 2025 | 3,782 | 0 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 28 Apr 2025 | 44 | 4,017 (0%) | 0% | 21.9 | 963 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2025 | 302 | 177,829 (0%) | 0% | - | Common Stock | |
| Uber | Mr. John Alexander Thain | Director | 16 Apr 2025 | 302 | 0 | - | - | Restricted Stock Units | ||
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Apr 2025 | 315 | 3,674 (0%) | 0% | 20.8 | 6,549 | Ords 0.29p | |
| Uber | Mr. John Alexander Thain | Director | 10 Apr 2025 | 302 | 302 | - | - | Restricted Stock Units | ||
| Ambarella Inc | Mr. John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 55.02 per share. | 18 Mar 2025 | 2,103 | 113,886 (0%) | 0% | 55.0 | 115,707 | Ordinary Shares |
| Diageo PLC (ADR) | Sir John Alexander Manzoni | Non-Executive Director,Chairman | 10 Mar 2025 | 299 | 3,359 (0%) | 0% | 21.9 | 6,554 | Ords 0.29p | |
| Precision Biosciences Inc | Mr. John Alexander Kelly | Chief Financial Officer | 03 Mar 2025 | 1,702 | 0 | - | - | Restricted Stock Units |